Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Entourage Health Corp (TSE:ENTG)
:ENTG
Holding TSE:ENTG?
Track your performance easily
Earnings Data
Report Date
May 05, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
―Last Year’s EPS
―Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 31, 2019
|% Change Since: 0.00%
|Next Earnings Date:May 31, 2019
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth, significant improvements in EBITDA, and successful product launches. However, these positives are balanced by challenges such as declining medical revenue, reduced selling prices, increased production costs, and a decrease in cash reserves. Despite these challenges, the company maintains a focus on operational efficiency and strategic growth.Company Guidance
During the third quarter of 2024, Entourage Health Corp. reported a total revenue increase of 11% year-over-year, reaching $13.6 million, with an improvement in EBITDA by 70% for the quarter and 65% year-over-year. The company achieved significant operational efficiencies, including a 32% reduction in SG&A expenses, contributing to enhanced margins. The production capacity was notably increased, with over 2 million pre-rolls produced monthly. The company expanded its product portfolio with 23 new SKUs, including innovative cannabis products under brands like Color Cannabis, Dime Bag, and Saturday, which added $2.5 million in incremental revenue. Despite a decrease in medical revenue by 7%, the adult-use segment remained stable, while bulk sales contributed an additional $1.1 million. The company ended the quarter with $3.5 million in cash and cash equivalents, reflecting a strategic focus on cost management and operational efficiency.Revenue Growth
The company achieved a total revenue of $13.6 million, reflecting an 11% year-over-year increase.
EBITDA Improvement
EBITDA increased by 70% this quarter and 65% year-over-year, demonstrating effective cost management and operational efficiency.
SG&A Expense Reduction
SG&A expenses decreased by 32% year-over-year, resulting in significant cost savings.
Successful Product Launches
The company launched 23 new SKUs across core brands, contributing to $2.5 million in incremental revenue and securing 2,000 new retail placements.
Operational Achievements in Pre-Roll Production
Production of over 2 million pre-rolls monthly, positioning the company to capitalize on growing demand.
---
TSE:ENTG Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TSE:ENTG Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 29, 2024 | C$0.01 | C$0.02 | +100.00% |
| Aug 26, 2024 | C$0.02 | C$0.01 | -50.00% |
| May 27, 2024 | C$0.01 | C$0.02 | +100.00% |
| Apr 30, 2024 | C$0.02 | C$0.02 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Entourage Health Corp (TSE:ENTG) report earnings?
Entourage Health Corp (TSE:ENTG) is schdueled to report earning on May 05, 2025, TBA Not Confirmed.
What is Entourage Health Corp (TSE:ENTG) earnings time?
Entourage Health Corp (TSE:ENTG) earnings time is at May 05, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:ENTG EPS forecast?
Currently, no data Available
---